Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone densitometry and bone biopsy.

Stuart H Ralston1

  • 1Bone Research Group, Institute of Medical Sciences, University of Aberdeen Medical School, Foresterhill, Aberdeen AB25 2ZD, UK. s.ralston@abdn.ac.uk

Best Practice & Research. Clinical Rheumatology
|June 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of anti-osteoporotic medication on fracture healing and outcomes: a systematic review and meta-analysis.

The lancet. Healthy longevity·2026
Same author

Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.

JAMA·2026
Same author

Large vessel vasculitis post granulocyte-colony stimulating factor (G-CSF) use in a patient undergoing neoadjuvant chemotherapy for pancreatic adenocarcinoma.

BMJ case reports·2026
Same author

Quantitative Sensory Testing Reveals Evidence of Altered Pain Processing in Paget's Disease of Bone.

Calcified tissue international·2025
Same author

What is the clinical and cost-effectiveness of surgery with Medial Opening wedge high TIbial Osteotomy compared with Non-surgical treatment (MOTION) in the management of osteoarthritis of the knee in patients younger than 60 years? : a protocol for a multicentre, randomized controlled trial.

Bone & joint open·2025
Same author

Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta.

Calcified tissue international·2025
Same journal

The young adult with Juvenile Idiopathic Arthritis (JIA): A clinical review of transition, complications, and psychosocial management.

Best practice & research. Clinical rheumatology·2026
Same journal

Impact of fatigue on rheumatic diseases: Current perspectives.

Best practice & research. Clinical rheumatology·2026
Same journal

Pneumocystis prophylaxis in rheumatic disease.

Best practice & research. Clinical rheumatology·2026
Same journal

Cutaneous manifestations in myositis syndromes.

Best practice & research. Clinical rheumatology·2026
Same journal

Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement.

Best practice & research. Clinical rheumatology·2026
Same journal

Alopecia across the spectrum of rheumatic disease.

Best practice & research. Clinical rheumatology·2026
See all related articles

Bone densitometry, particularly dual-energy X-ray absorptiometry (DXA), is crucial for diagnosing and managing osteoporosis. It accurately measures bone mineral density (BMD) to guide treatment and monitor therapy effectiveness.

Area of Science:

  • Orthopedics and Endocrinology
  • Radiology and Nuclear Medicine

Background:

  • Osteoporosis diagnosis and management rely heavily on bone mineral density (BMD) measurements.
  • Dual-energy X-ray absorptiometry (DXA) is the current gold standard for BMD assessment due to its precision and low radiation exposure.
  • BMD data is essential for initiating and selecting appropriate osteoporosis treatments.
  • Monitoring treatment response also depends on BMD measurements.

Purpose of the Study:

  • To highlight the importance of bone densitometry in osteoporosis assessment and management.
  • To emphasize the role of DXA as the preferred method for measuring BMD.
  • To underscore the utility of BMD in guiding and monitoring osteoporosis therapy.

Main Methods:

  • Dual-energy X-ray absorptiometry (DXA) is the primary method discussed for measuring bone mineral density (BMD).

Related Experiment Videos

  • Transiliac bone biopsy is presented as an indicated investigation for specific metabolic bone diseases when other methods are inconclusive.

    • Main Results:

    • DXA offers high precision and a low radiation dose for BMD measurement.
    • BMD measurements are critical for treatment decisions and monitoring therapy in osteoporosis patients.
    • Transiliac bone biopsy is valuable in differentiating infiltrative disorders from primary bone cell function abnormalities in selected cases.

    Conclusions:

    • Bone densitometry, especially DXA, is indispensable for osteoporosis diagnosis, treatment selection, and therapy monitoring.
    • Transiliac bone biopsy serves a vital role in complex metabolic bone disease cases requiring detailed investigation.